ED Visits for Schizophrenia Spectrum Disorders Up After Pandemic Onset

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Dec. 27, 2023 -- The number of emergency department visits for schizophrenia spectrum disorders increased after the onset of the COVID-19 pandemic, according to a study published online Dec. 27 in JAMA Network Open.

Parvati Singh, Ph.D., from The Ohio State University in Columbus, and colleagues examined monthly patterns of emergency department visits for schizophrenia spectrum disorders after the onset of the COVID-19 pandemic in an observational cohort study using time-series analyses. Emergency department visits for schizophrenia spectrum disorders and all other psychiatric emergency department visits were identified from January 2016 to December 2021 at five University of California campuses.

Data were included for 377,872 psychiatric emergency department visits, of which 37,815 visits were for schizophrenia spectrum disorders. The researchers found that for schizophrenia spectrum disorders, the prepandemic monthly mean number of emergency department visits was 519.9, which increased to 558.4 after COVID-19 pandemic onset. Controlling for monthly counts of emergency department visits for all other psychiatric conditions, the results from time series analyses indicated 70.5 and 74.9 additional visits for schizophrenia spectrum disorders at one and three months, respectively, following the initial phase of the COVID-19 pandemic.

"The COVID-19 pandemic draws attention to the vulnerability of patients with schizophrenia to macrosocial shocks, underscoring the importance of social policies related to income support, housing, and health insurance for future emergency preparedness and the need to strengthen mental health care systems," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords